Opioid Overdose

Predictors of Opioid Overdose in High-Risk Users

Predictors of Opioid Overdose in High-Risk Users

By

Having a hepatitis C virus infection, witnessing a friend or others experiencing a drug overdose, and having a history of frequent buprenorphine treatment are factors that may predict the risk for opioid drug overdose in high-risk opioid users.

Insurance Company Sets Goal for Reducing Opioid Overdoses by 25%

Insurance Company Sets Goal for Reducing Opioid Overdoses by 25%

By

Through their predictive analytics, Cigna can identify customers most likely to suffer from an overdose and can prompt interventions.

Deaths After Nonfatal Opioid Overdose: Causes and Risk Factors

Deaths After Nonfatal Opioid Overdose: Causes and Risk Factors

By

Causes of death in the year after a nonfatal opioid overdose were often related to substance use disorders, as well as to a range of mental health and medical conditions.

Greater Number of Opioid Prescribers Associated With Higher Overdose Risk

Greater Number of Opioid Prescribers Associated With Higher Overdose Risk

By

Among the patterns that may increase the risk for opioid overdose, receiving opioids from >1 vs 1 prescriber/pharmacy is predominant.

Treatment for Opioid Use Disorder Associated With Reduced Risk for Opioid-Related Deaths

Treatment for Opioid Use Disorder Associated With Reduced Risk for Opioid-Related Deaths

By

Few of the individuals who experience an opioid-related overdose had received treatment for opioid use disorder.

Tamper-Resistant Controlled-Release Oxycodone and Opioid Use: A Population Study

Tamper-Resistant Controlled-Release Oxycodone and Opioid Use: A Population Study

By

A new tamper-resistant formulation of controlled-release oxycodone was not found to reduce opioid use or harm at the population level.

Investigational Oxycodone Vaccine Shows Potential for Oxycodone Abuse, Overdose

Investigational Oxycodone Vaccine Shows Potential for Oxycodone Abuse, Overdose

By

An investigational vaccine may represent an effective treatment strategy for oxycodone abuse and may help reduce oxycodone overdose severity.

New Consensus Statement Establishes Guidelines on Urine Drug Monitoring in Chronic Pain

New Consensus Statement Establishes Guidelines on Urine Drug Monitoring in Chronic Pain

By

New guidelines were formulated for the use of urine drug monitoring in risk stratification and the prevention of opioid use disorder, overdose, and diversion.

Efficacy, Tolerability of Intranasal vs Intramuscular Naloxone for Opioid Overdose

Efficacy, Tolerability of Intranasal vs Intramuscular Naloxone for Opioid Overdose

By

Intranasal naloxone may have comparable efficacy and tolerability to intramuscular naloxone.

Illicit Fentanyl Linked to More Than Half of US Overdose Deaths

Illicit Fentanyl Linked to More Than Half of US Overdose Deaths

Fentanyl was detected in more than half of the 5152 opioid overdose deaths in 10 states from July through December of 2016.

Walgreens to Carry Naloxone in All Pharmacies to Combat Drug Abuse

Walgreens to Carry Naloxone in All Pharmacies to Combat Drug Abuse

By

Narcan Nasal Spray, an opioid antagonist, is indicated for the reversal of known or suspected opioid overdose, including respiratory and/or central nervous system depression.

Balanced Pain Management and Overdose Prevention Strategies

Balanced Pain Management and Overdose Prevention Strategies

By

At PAINWeek 2017, the president of the National Association of Drug Diversion Investigators discussed ways to balance pain management needs and overdose prevention measures.

Screeners to Predict Opioid Misuse in Patients With Chronic Pain

Screeners to Predict Opioid Misuse in Patients With Chronic Pain

By

Rates of opioid misuse and related overdoses have soared in recent years in the United States, highlighting the importance of screening tools to identify patients at high risk for adverse events from opioid use.

Strategies to Curb the Opioid Epidemic: A National Academies Report

Strategies to Curb the Opioid Epidemic: A National Academies Report

By

Highlights from the National Academies of Sciences, Engineering, and Medicine report titled "Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use."

Opioid Prescriptions Remains High According to CDC

Opioid Prescriptions Remains High According to CDC

By

According to the CDC, despite reductions in certain parts of the country, the amount of opioids being prescribed remains high compared with levels in 1999, with variations mostly seen at the county level.

Majority of Opioid Rx for Patients With Mental Disorders

Majority of Opioid Rx for Patients With Mental Disorders

By

More than half of all opioids prescribed in the United States are for patients who have a mental health disorder.

Long-Term Opioids Associated With Worse Functional Status, Adverse Events in Polyneuropathy

Long-Term Opioids Associated With Worse Functional Status, Adverse Events in Polyneuropathy

By

Polyneuropathy may increase the likelihood of patients receiving long-term opioid therapy.

ED Physicians' Role In Opioid Misuse

ED Physicians' Role In Opioid Misuse

By

Researchers reviewed studies that examined the role of emergency department doctors in the US opioid epidemic.

Prescription Opioid Crisis: Public Health Response in Pennsylvania

Prescription Opioid Crisis: Public Health Response in Pennsylvania

By

Pennsylvania has adopted a multipronged approach to address the opioid crisis.

How CDC Opioid Prescribing Guidelines Affect PCPs

How CDC Opioid Prescribing Guidelines Affect PCPs

By

Dr McCarberg reviewed each component of the guideline and explored how it may benefit or impede a PCP's ability to provide effective pain management.

CDC Report: Risks of Death in Rural America

CDC Report: Risks of Death in Rural America

Americans who live in rural areas have a higher risk of death from 5 leading causes than people who live in urban locations.

Naloxone Price Hikes Affecting Efforts to Combat Opioid-Related Deaths?

Naloxone Price Hikes Affecting Efforts to Combat Opioid-Related Deaths?

Should the government do more to ensure that naloxone is affordable?

The Clinton Foundation's Work to Expand Access to Naloxone

The Clinton Foundation's Work to Expand Access to Naloxone

By

The Clinton Health Matters Initiative, a branch of the Clinton Foundation, in partnership with Adapt Pharma, recently announced the distribution of 10 000 doses of Narcan nasal spray.

FDA Holding App Development Contest To Increase Naloxone Accessibility

FDA Holding App Development Contest To Increase Naloxone Accessibility

By

No application is currently available to connect carriers of naloxone with nearby opioid overdose victims.

The Issues With the CDC Guidelines on Opioids for Chronic Pain, According to AAPM's Director

The Issues With the CDC Guidelines on Opioids for Chronic Pain, According to AAPM's Director

By

Dr Twillman extensively emphasized the fact that these CDC guidelines are expert- and not evidence-based.

U.S. Medical Schools to Expand Training on Opioid Abuse

U.S. Medical Schools to Expand Training on Opioid Abuse

Health experts note that opioids are prescribed too often, possibly because of poor training

Long-Term Use More Likely With Opioids vs NSAIDs for Low Back Pain

Long-Term Use More Likely With Opioids vs NSAIDs for Low Back Pain

By

Researchers identified patterns of opioid and NSAID use among patients with low back pain.

Behavioral Interventions in the ED Can Reduce Risk of Opioid Overdose

Behavioral Interventions in the ED Can Reduce Risk of Opioid Overdose

By

Combination of a motivational interviewing and enhanced brochures successful in reducing behaviors associated with opioid overdose.

Daily Pain Variations: A Weak Link to Opioid Craving

Daily Pain Variations: A Weak Link to Opioid Craving

By

Craving is known to be influenced by patient-specific variables such as sex, negative affect, and history of SUD,but few studies have examined the impact of day-to-day changes in pain intensity.

Sign Up for Free e-Newsletters